winifred carson-smith - Academia.edu (original) (raw)
Uploads
Papers by winifred carson-smith
PubMed, 1998
This article discusses the history of certification process and distinguishes and analyzes past a... more This article discusses the history of certification process and distinguishes and analyzes past and present uses of the certification process. It explores changes in the regulatory process and the impact on nurse licensure and evaluates past, present, and future uses of certification related to advanced practice, credentialing, and the scope of nursing practice.
Clinical Nurse Specialist, 2007
1 Health Care and Education Reconciliation Act of 2010, Public Law 111–52, 124 Stat. 1029 (2010);... more 1 Health Care and Education Reconciliation Act of 2010, Public Law 111–52, 124 Stat. 1029 (2010); Patient Protection and Affordable Care Act, Public Law 111–48, 124 Stat. 119 (2010). 2 As used in this document, ‘‘ACO’’ refers to Accountable Care Organizations under the Medicare Shared Savings Program, which also may operate in commercial markets. Patient Protection and Affordable Care Act 3022, 124 Stat. at 395–99. 3 Id. 4 Id. at 395. 5 Id. at 396. 6 Fed. Trade Comm’n & Dep’t of Health and Human Serv., Workshop Regarding Accountable Care Organizations, and Implications Regarding Antitrust, Physician Self-Referral, Anti-Kickback, and Civil Monetary Penalty (CMP) Laws (Oct. 5, 2010). 7 The analytical principles underlying the Policy Statement also would apply to various ACO initiatives undertaken by the Innovation Center within CMS as long as those ACOs are substantially clinically or financially integrated. FEDERAL TRADE COMMISSION
The Nurse Practitioner, 1993
The American Journal of Nursing, Nov 30, 2001
The Nursing Clinics of North America, 2000
With the evolution of genetic research, legal issues have emerged related to the health care deli... more With the evolution of genetic research, legal issues have emerged related to the health care delivery industry and the protection of patient information. The use of genetics or genetic enhancement expands the role of the nurse and also brings a new perspective to the nurse-patient relationship. Nurses now must discern their role in relation to patient privacy and confidentiality. In addition to reviewing the ethical and legal dilemmas of registered nurses in clinical practice, the nursing profession must review the level of responsibility appropriate when using genetic and or experimental treatments, especially when the nurse is not the primary care provider or the leader of the research team. Nurses will have to delve into privacy and confidentiality issues associated with genetic research. Although little case law exists on the relationship of nursing to genetic research and treatments, the implications of experimental research and policy associated with genetics must be analyzed to better understand their impact on the scope of nursing practice.
The Nurse Practitioner, 1993
The Nurse Practitioner, 2003
Clinical Nurse Specialist, 2007
... From the Division of Nursing, Howard University, Washington, DC; Humphries and Brooks, and Nu... more ... From the Division of Nursing, Howard University, Washington, DC; Humphries and Brooks, and Nursing Insurers Association of America, Washington, DC (Dr Carson-Smith); and Department of Health Care Nursing at the ... Dallas, Tex: Federation of State Medical Boards; 2006. ...
American Journal of Nursing, 2001
American Journal of Nursing, 2001
The Nurse Practitioner, 2003
PubMed, 1998
This article discusses the history of certification process and distinguishes and analyzes past a... more This article discusses the history of certification process and distinguishes and analyzes past and present uses of the certification process. It explores changes in the regulatory process and the impact on nurse licensure and evaluates past, present, and future uses of certification related to advanced practice, credentialing, and the scope of nursing practice.
Clinical Nurse Specialist, 2007
1 Health Care and Education Reconciliation Act of 2010, Public Law 111–52, 124 Stat. 1029 (2010);... more 1 Health Care and Education Reconciliation Act of 2010, Public Law 111–52, 124 Stat. 1029 (2010); Patient Protection and Affordable Care Act, Public Law 111–48, 124 Stat. 119 (2010). 2 As used in this document, ‘‘ACO’’ refers to Accountable Care Organizations under the Medicare Shared Savings Program, which also may operate in commercial markets. Patient Protection and Affordable Care Act 3022, 124 Stat. at 395–99. 3 Id. 4 Id. at 395. 5 Id. at 396. 6 Fed. Trade Comm’n & Dep’t of Health and Human Serv., Workshop Regarding Accountable Care Organizations, and Implications Regarding Antitrust, Physician Self-Referral, Anti-Kickback, and Civil Monetary Penalty (CMP) Laws (Oct. 5, 2010). 7 The analytical principles underlying the Policy Statement also would apply to various ACO initiatives undertaken by the Innovation Center within CMS as long as those ACOs are substantially clinically or financially integrated. FEDERAL TRADE COMMISSION
The Nurse Practitioner, 1993
The American Journal of Nursing, Nov 30, 2001
The Nursing Clinics of North America, 2000
With the evolution of genetic research, legal issues have emerged related to the health care deli... more With the evolution of genetic research, legal issues have emerged related to the health care delivery industry and the protection of patient information. The use of genetics or genetic enhancement expands the role of the nurse and also brings a new perspective to the nurse-patient relationship. Nurses now must discern their role in relation to patient privacy and confidentiality. In addition to reviewing the ethical and legal dilemmas of registered nurses in clinical practice, the nursing profession must review the level of responsibility appropriate when using genetic and or experimental treatments, especially when the nurse is not the primary care provider or the leader of the research team. Nurses will have to delve into privacy and confidentiality issues associated with genetic research. Although little case law exists on the relationship of nursing to genetic research and treatments, the implications of experimental research and policy associated with genetics must be analyzed to better understand their impact on the scope of nursing practice.
The Nurse Practitioner, 1993
The Nurse Practitioner, 2003
Clinical Nurse Specialist, 2007
... From the Division of Nursing, Howard University, Washington, DC; Humphries and Brooks, and Nu... more ... From the Division of Nursing, Howard University, Washington, DC; Humphries and Brooks, and Nursing Insurers Association of America, Washington, DC (Dr Carson-Smith); and Department of Health Care Nursing at the ... Dallas, Tex: Federation of State Medical Boards; 2006. ...
American Journal of Nursing, 2001
American Journal of Nursing, 2001
The Nurse Practitioner, 2003